Prescription drug · ANDA
Dutasteride NDC 59651-021
Dutasteride .5 mg/1 · Capsule, Liquid filled · Oral · Aurobindo Pharma Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 59651-021-30 | 59651002130 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (59651-021-30)Marketed from Jan 20, 2023 | |
| 59651-021-90 | 59651002190 | 90 CAPSULE, LIQUID FILLED in 1 BOTTLE (59651-021-90)Marketed from Jan 20, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Dutasteride
- Generic name (nonproprietary)
- dutasteride
- Active ingredients
- Dutasteride — .5 mg/1
- Dosage form
- Capsule, Liquid filled
- Route
- Oral
- Labeler
- Aurobindo Pharma LimitedNDC labeler code 59651
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202660
- Marketing start
- Listing expires
- Other FDA classes
- 5-alpha Reductase Inhibitors (Mechanism)
- Identifiers
- Product ID 59651-021_cfb5a2a0-be39-4ef5-b115-47ba5a4b7dd3SPL ID cfb5a2a0-be39-4ef5-b115-47ba5a4b7dd3SPL set ID b32611f3-50ec-45bb-a671-ea10cec7829dRxCUI 351172UNII O0J6XJN02IUPC 0359651021309
- Pharmacologic class
- 5-alpha Reductase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N459651002130followed by a unit qualifier and the quantityPackage 59651-0021-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Dutasteride capsules are a 5 alpha-reductase inhibitor indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to: ( 1.1 ) improve symptoms, reduce the risk of acute urinary retention, and reduce the risk of the need for BPH-related surgery. Dutasteride in combination with the alpha-adrenergic antagonist, tamsulosin, is indicated for the treatment of symptomatic BPH in men with an enlarged prostate. ( 1.2 ) Limitations of Use: Dutasteride capsules are not approved for the prevention of prostate cancer. ( 1.3 ) 1.1 Monotherapy Dutasteride capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men wit…
Excerpt only. Read the full label for complete information.
About NDC 59651-021
- What is NDC 59651-021?
- 59651-021 is the product NDC for Dutasteride, Dutasteride .5 mg/1 capsule, liquid filled, listed with the FDA by Aurobindo Pharma Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Dutasteride.
- What is the active ingredient?
- Dutasteride.
- Who is the labeler?
- Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Dutasteride?
- 20 other product NDCs are listed under this name. See all Dutasteride NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Dutasteride products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Dutasteride | Dutasteride .5 mg/1 | CapsuleOral | Banyan Pharma LLC | 84091-100 | 84091-0100-90 |
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | A-S Medication Solutions | 50090-7305 | 50090-7305-0050090-7305-01 |
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | XLCare Pharmaceuticals, Inc. | 72865-140 | 72865-0140-3072865-0140-90 |
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | NuCare Pharmaceuticals, Inc. | 68071-3757 | 68071-3757-06 |
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | A-S Medication Solutions | 50090-7852 | 50090-7852-0050090-7852-01 |
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | NuCare Pharmaceuticals, Inc. | 68071-3857 | 68071-3857-09 |
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | Epic Pharma, LLC | 42806-549 | 42806-0549-0942806-0549-30 |
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | MARKSANS PHARMA LIMITED | 25000-011 | 25000-0011-0325000-0011-0725000-0011-27 |
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | Strides Pharma Science Limited | 64380-763 | 64380-0763-0464380-0763-05 |
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | Bryant Ranch Prepack | 63629-1222 | 63629-1222-01 |
Other NDCs under ANDA 202660
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Dutasteride | Dutasteride .5 mg/1 | Capsule, Liquid filledOral | A-S Medication Solutions | 50090-7305 |